Collegium Pharmaceutical, Inc.

Collegium Pharmaceutical Beats on EPS, Stock Up 0.81%

Collegium Pharmaceutical reported strong earnings with an EPS beat of over 15%, which contributed to a modest stock increase of 0.81%. However, there was no revenue data or guidance provided, leaving some uncertainty about future performance. Investors may view the EPS surprise positively, but the lack of additional context from management could lead to cautious sentiment.